PhyMedExp, INSERM U1046, CNRS UMR 9214, Montpellier University, Montpellier, France.
Air+R Network, Montpellier University, Montpellier, France.
Respir Res. 2021 Mar 10;22(1):79. doi: 10.1186/s12931-021-01674-3.
Pulmonary rehabilitation (PR) improves exercise capacity, health-related quality of life (HRQoL) and dyspnea in chronic obstructive pulmonary disease (COPD) patients. Maintenance programs can sustain the benefits for 12 to 24 months. Yet, the long-term effects (> 12 months) of pragmatic maintenance programs in real-life settings remain unknown. This prospective cohort study assessed the yearly evolution in the outcomes [6-min walking distance (6MWD), HRQoL, dyspnea] of a supervised self-help PR maintenance program for COPD patients followed for 5 years. The aim was to assess the change in the outcomes and survival probability for 1 to 5 years after PR program discharge in COPD patients following a PR maintenance program supported by supervised self-help associations.
Data were prospectively collected from 144 COPD patients who followed a pragmatic multidisciplinary PR maintenance program for 1 to 5 years. They were assessed yearly for 6MWD, HRQol (VQ11) and dyspnea (MRC). The 5-year survival probability was compared to that of a control PR group without a maintenance program. A trajectory-based cluster analysis identified the determinants of long-term response.
Maintenance program patients showed significant PR benefits at 4 years for 6MWD and VQ11 and 5 years for MRC. The 5-year survival probability was higher than for PR patients without PR maintenance. Two clusters of response to long-term PR were identified, with responders being the less severe COPD patients.
This study provides evidence of the efficacy of a pragmatic PR maintenance program in a real-life setting for more than 3 years. In contrast to short-term PR, long-term PR maintenance appeared more beneficial in less severe COPD patients.
肺康复(PR)可改善慢性阻塞性肺疾病(COPD)患者的运动能力、健康相关生活质量(HRQoL)和呼吸困难。维持方案可维持 12 至 24 个月的疗效。然而,现实环境中实用维持方案的长期效果(>12 个月)仍不清楚。本前瞻性队列研究评估了 COPD 患者接受监督自我帮助 PR 维持方案治疗 5 年后,每年结局(6 分钟步行距离(6MWD)、HRQoL、呼吸困难)的演变情况。目的是评估在 PR 计划出院后 1 至 5 年内,接受监督自我帮助协会支持的 PR 维持计划的 COPD 患者的结局变化和生存概率。
前瞻性收集了 144 名接受实用多学科 PR 维持方案治疗 1 至 5 年的 COPD 患者的数据。每年对他们进行 6MWD、HRQol(VQ11)和呼吸困难(MRC)评估。将 5 年生存率与未接受 PR 维持计划的 PR 对照组进行比较。基于轨迹的聚类分析确定了长期反应的决定因素。
维持方案患者在 4 年时 6MWD 和 VQ11 以及 5 年时 MRC 显示出显著的 PR 获益。5 年生存率高于未接受 PR 维持的 PR 患者。确定了对长期 PR 的两种反应聚类,其中反应者是 COPD 病情较轻的患者。
这项研究为现实环境中实用 PR 维持方案在 3 年以上的疗效提供了证据。与短期 PR 不同,长期 PR 维持在病情较轻的 COPD 患者中似乎更有益。